CyclophosphamideTumour lysis syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1765卷 / 1期

关键词：

D O I：

10.1007/s40278-019-65888-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：131 / 131

相关论文

共 50 条

[31] SorafenibTumour lysis syndrome: case report
Reactions Weekly, 2014, 1521 (1) : 149 - 149
[32] DoxorubicinTumour lysis syndrome: case report
Reactions Weekly, 2022, 1922 (1) : 238 - 238
[33] CetuximabTumour lysis syndrome: case report
Reactions Weekly, 2010, 1320 (1) : 16 - 16
[34] ImatinibTumour lysis syndrome: case report
Reactions Weekly, 2009, 1242 (1) : 30 - 30
[35] CisplatinTumour lysis syndrome: case report
Reactions Weekly, 2009, 1263 (1) : 12 - 12
[36] BortezomibTumour lysis syndrome: case report
Reactions Weekly, 2006, 1092 (1) : 9 - 9
[37] AntineoplasticsTumour lysis syndrome: case report
Reactions Weekly, 2018, 1725 (1) : 40 - 40
[38] VenetoclaxTumour lysis syndrome: case report
Reactions Weekly, 2019, 1738 (1) : 262 - 262
[39] PaclitaxelTumour lysis syndrome: case report
Reactions Weekly, 2006, 1129 (1) : 17 - 17
[40] IbrutinibTumour lysis syndrome: case report
Reactions Weekly, 2020, 1833 (1) : 197 - 197

← 1 2 3 4 5 →